Tandem Diabetes Care, Inc. (FRA:TD5A)

Tandem Diabetes Care Statistics

Total Valuation

FRA:TD5A has a market cap or net worth of EUR 1.42 billion. The enterprise value is 1.56 billion.

Market Cap	1.42B
Enterprise Value	1.56B

Important Dates

The last earnings date was Thursday, February 19, 2026.

Earnings Date	Feb 19, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	68.33M
Shares Outstanding	n/a
Shares Change (YoY)	+2.80%
Shares Change (QoQ)	+0.54%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	62.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.65
PB Ratio	10.78
P/TBV Ratio	11.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.94
EV / Sales	1.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-61.65

Financial Position

The company has a current ratio of 2.55, with a Debt / Equity ratio of 2.90.

Current Ratio	2.55
Quick Ratio	1.89
Debt / Equity	2.90
Debt / EBITDA	n/a
Debt / FCF	-15.15
Interest Coverage	-9.88

Financial Efficiency

Return on equity (ROE) is -97.88% and return on invested capital (ROIC) is -26.94%.

Return on Equity (ROE)	-97.88%
Return on Assets (ROA)	-5.28%
Return on Invested Capital (ROIC)	-26.94%
Return on Capital Employed (ROCE)	-12.24%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	345,700
Profits Per Employee	-69,741
Employee Count	2,650
Asset Turnover	1.10
Inventory Turnover	3.37

Taxes

In the past 12 months, FRA:TD5A has paid 3.78 million in taxes.

Income Tax	3.78M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -48.16% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-48.16%
50-Day Moving Average	17.50
200-Day Moving Average	14.92
Relative Strength Index (RSI)	45.14
Average Volume (20 Days)	19

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.49

Income Statement

In the last 12 months, FRA:TD5A had revenue of EUR 864.25 million and -174.35 million in losses. Loss per share was -2.59.

Revenue	864.25M
Gross Profit	465.04M
Operating Income	-66.54M
Pretax Income	-170.57M
Net Income	-174.35M
EBITDA	-51.49M
EBIT	-66.54M
Loss Per Share	-2.59

Balance Sheet

The company has 249.26 million in cash and 382.73 million in debt, with a net cash position of -133.47 million.

Cash & Cash Equivalents	249.26M
Total Debt	382.73M
Net Cash	-133.47M
Net Cash Per Share	n/a
Equity (Book Value)	132.16M
Book Value Per Share	1.94
Working Capital	319.74M

Cash Flow

In the last 12 months, operating cash flow was -8.28 million and capital expenditures -16.99 million, giving a free cash flow of -25.27 million.

Operating Cash Flow	-8.28M
Capital Expenditures	-16.99M
Free Cash Flow	-25.27M
FCF Per Share	n/a

Margins

Gross margin is 53.81%, with operating and profit margins of -7.70% and -20.17%.

Gross Margin	53.81%
Operating Margin	-7.70%
Pretax Margin	-19.74%
Profit Margin	-20.17%
EBITDA Margin	-5.96%
EBIT Margin	-7.70%
FCF Margin	n/a

Dividends & Yields

FRA:TD5A does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.80%
Shareholder Yield	-2.80%
Earnings Yield	-12.24%
FCF Yield	-1.77%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 10, 2017. It was a reverse split with a ratio of 0.1.

Last Split Date	Oct 10, 2017
Split Type	Reverse
Split Ratio	0.1

Scores

FRA:TD5A has an Altman Z-Score of 0.48 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.48
Piotroski F-Score	3